Lv CL - Search Results

1

Alternative splicing and intron retention: Their profiles and roles in cutaneous fibrosis of systemic sclerosis.

Xie S, Bao D, Xiao Y, Li H, Guo M, Dai B, Liu S, Huang J, Li M, Ding L, Meng Q, Lv CL, Distler JHW, Luo H, Zhu H. Xie S, et al. Among authors: lv cl. J Autoimmun. 2024 Dec;149:103306. doi: 10.1016/j.jaut.2024.103306. Epub 2024 Sep 12. J Autoimmun. 2024. PMID: 39265192

2

The role and mechanism of CRISPLD2 in skin fibrosis of systemic sclerosis.

Ding L, Bao D, Dai B, Meng Q, Lv C, Zhu H, Luo H. Ding L, et al. Rheumatology (Oxford). 2024 Oct 7:keae541. doi: 10.1093/rheumatology/keae541. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 39374552

3

ADAM Metallopeptidase domain 19 promotes skin fibrosis in systemic sclerosis via neuregulin-1.

Meng Q, Bao D, Liu S, Huang J, Guo M, Dai B, Ding L, Xie S, Meng M, Lv C, He W, Luo H, Zhu H. Meng Q, et al. Mol Med. 2024 Dec 23;30(1):269. doi: 10.1186/s10020-024-01047-8. Mol Med. 2024. PMID: 39716051 Free PMC article.

4

Construction of a prognostic model based on cuproptosis-related patterns for predicting survival, immune infiltration, and immunotherapy efficacy in breast cancer: Cuproptosis-based prognostic modeling in breast cancer.

Tang Y, Lv C, Luo Z, Li Z, Yu J. Tang Y, et al. Medicine (Baltimore). 2024 Nov 1;103(44):e40136. doi: 10.1097/MD.0000000000040136. Medicine (Baltimore). 2024. PMID: 39496015 Free PMC article.

5

MicroRNA profiling in denatured dermis of deep burn patients.

Liang P, Lv C, Jiang B, Long X, Zhang P, Zhang M, Xie T, Huang X. Liang P, et al. Burns. 2012 Jun;38(4):534-40. doi: 10.1016/j.burns.2011.10.014. Epub 2012 Feb 22. Burns. 2012. PMID: 22360957

6

Cancer-associated fibroblasts-derived lncRNA signature as a putative biomarker in breast cancer.

Li Z, Yu J, Lv C, Luo Z. Li Z, et al. Front Oncol. 2022 Nov 2;12:1028664. doi: 10.3389/fonc.2022.1028664. eCollection 2022. Front Oncol. 2022. PMID: 36408190 Free PMC article.

7

ABCA8 inhibits breast cancer cell proliferation by regulating the AMP activated protein kinase/mammalian target of rapamycin signaling pathway.

Lv C, Yang H, Yu J, Dai X. Lv C, et al. Environ Toxicol. 2022 Jun;37(6):1423-1431. doi: 10.1002/tox.23495. Epub 2022 Feb 22. Environ Toxicol. 2022. PMID: 35191604

8

The cytotoxicity of karanjin toward breast cancer cells is involved in the PI3K/Akt signaling pathway.

Yu J, Yang H, Lv C, Dai X. Yu J, et al. Drug Dev Res. 2022 Nov;83(7):1673-1682. doi: 10.1002/ddr.21986. Epub 2022 Sep 6. Drug Dev Res. 2022. PMID: 36065628

9

Crocin suppresses breast cancer cell proliferation by down-regulating tumor promoter miR-122-5p and up-regulating tumor suppressors FOXP2 and SPRY2.

Jia Y, Yang H, Yu J, Li Z, Jia G, Ding B, Lv C. Jia Y, et al. Environ Toxicol. 2023 Jul;38(7):1597-1608. doi: 10.1002/tox.23789. Epub 2023 Mar 29. Environ Toxicol. 2023. PMID: 36988377

10

lncRNA‑MIAT facilitates the differentiation of adipose‑derived mesenchymal stem cells into lymphatic endothelial cells via the miR‑495/Prox1 axis.

Dai XW, Luo W, Lv CL. Dai XW, et al. Among authors: lv cl. Mol Med Rep. 2021 May;23(5):323. doi: 10.3892/mmr.2021.11962. Epub 2021 Mar 24. Mol Med Rep. 2021. PMID: 33760182

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

77 results

Search Page

Filters